Compounding Committee News Today

The talmud teaches that if a person destroys one life, it is as if they have destroyed an entire world. And if a person saves one life, it is as if theyve saved an entire world. What an extraordinary honor to be with us as we honor four righteous individuals whose courage is measured in the lives they saved. One child. O one refugee. One comrade at a time. And who, in so doing, helped save our world. I deliver a lot of speeches. Very rarely am i so humbled by the eloquence that has preceded me. ...

My my mother was 54. I thought about my last conversation with her. When she implored that she spent all of her savings if she had no chance to live. Of course she had no chance to live where told that she would not live beyond eight months. And we spend all of her savings. They thought about what that does to families. The question is why . Most of us come to Congress Bring with us our experiences we try to answer through service that question why. Every session i sat through theres a common th...

Last week, NCPA hosted the intrepid members of its steering committees for the annual NCPA Steering Committee Forum — some of the best and brightest pharmacy owners from around the country who spent two days helping NCPA keep its finger on the pulse of independent pharmacy. Coming off a productive annual convention in Orlando last month, attendees from six standing committees gathered at NCPA’s headquarters in Alexandria, Va., between Nov. 7 and Nov. 9.

Dear Colleague, There's a time for planning and there's a time for doing—and one of the great things about NCPA's annual Steering Committee Forum is that it's a time for both.

This annual award recognizes excellence and leadership in pharmacy compounding....

USP presented to NCPA’s Compounding Committee on its revised compounding chapters (Pharmaceutical Compounding – Sterile Preparations) and (Pharmaceutical Compounding – Sterile Preparations). Click here for more information on the revisions. USP published updates to these chapters in the USP-NF and USP Compounding Compendium on Nov. 1.

By a 9-5 vote on Wednesday, PCAC members recommended that the FDA keep methylcobalamin on the 503A Bulk List, voting against FDA’s recommendation. Before the meeting NCPA submitted comments in favor of the inclusion. We were represented at the meeting NCPA member A.J. Day, a member of the Compounding Committee, who highlighted the importance of the availability of methylcobalamin for patients with Autism Spectrum Disorder. FDA is not obligated to PCAC’s advice, but they do consider the input...